Document is current
Any future updates will be listed below
-
Authors
Takayama, Shin https://orcid.org/0000-0002-6388-4566
Namiki, Takao
Ito, Takashi
Arita, Ryutaro
Nakae, Hajime
Kobayashi, Seiichi
Yoshino, Tetsuhiro
Ishigami, Tomoaki
Tanaka, Koichiro
Kainuma, Mosaburo
Nochioka, Kotaro
Takagi, Airi
Mimura, Masaru
Yamaguchi, Takuhiro
Ishii, Tadashi
-
Funding
Funding for this research was provided by:
Tsumura and Company
- License Information
-
More Information
Article History
Received: 11 September 2020
Accepted: 16 September 2020
First Online: 2 October 2020
Ethics approval and consent to participate
: This protocol was approved by the MHLW Certified Clinical Research Review Board, Tohoku University, Sendai, Miyagi, Japan, on August 4, 2020 (Certification No. CRB2180001). The authors certify that this trial has received ethical approval from the appropriate ethical committee as described above.Before inclusion in the study, conscious patients will be informed of the purpose and clinical procedures required by the protocol. The investigators in each hospital or clinic will explain the purpose, risks, and benefits associated with study participation. Also, patients will be informed of their right to withdraw from the study at any time without explanation and without losing the right to future medical care. Every patient is free to leave the study protocol at any stage of the study and can request to retire his consent and, consequently, ask for the elimination of all his data from the database.
: Not applicable.
: S.T. and T.I. belong to the Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, a joint research course with TSUMURA and Co., which is a paratheatrical company of Kampo medicine in Japan.
